Contineum Therapeutics . Class A Common Stock Stock Forecast

Buy or Hold candidate since Jul 08, 2026 Loss -1.02%

The Contineum Therapeutics, Inc. Class A stock price fell by -1.65% on the last day (Friday, 31st Jul 2026) from $15.75 to $15.49. During the last trading day the stock fluctuated 13.78% from a day low at $14.15 to a day high of $16.10. The price has been going up and down for this period, and there has been a 8.85% gain for the last 2 weeks. Volume has increased on the last day by 111 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 448 thousand shares were bought and sold for approximately $6.95 million.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 8.50% during the next 3 months and, with a 90% probability hold a price between $13.08 and $18.30 at the end of this 3-month period.

CTNM Signals & Forecast

There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Thursday, July 30, 2026, and so far it has fallen -1.65%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. The Contineum Therapeutics, Inc. Class A stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $14.58 and $14.04. A breakdown below any of these levels will issue sell signals.

Support, Risk & Stop-loss for Contineum Therapeutics, Inc. Class A stock

On the downside, the stock finds support just below today's level from accumulated volume at $14.19 and $14.15. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Contineum Therapeutics, Inc. Class A finds support just below today's level at $14.19. If this is broken, then the next support from accumulated volume will be at $14.15 and $12.40.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.95 between high and low, or 13.78%. For the last week, the stock has had daily average volatility of 9.33%.

Our recommended stop-loss: $14.95 (-3.49%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (CTNM) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Contineum Therapeutics, Inc. Class A Common Stock to open at $15.25, and during the day (based on 14 day Average True Range), to move between $14.94 and $16.04, which gives a possible trading interval of +/-$1.09 (+/-7.30%) up or down from last closing price. If Contineum Therapeutics, Inc. Class A Common Stock takes out the full calculated possible swing range there will be an estimated 7.30% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $15.53 (0.26%) than the support at $14.19 (8.39%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Contineum Therapeutics, Inc. Class A Common Stock stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Contineum Therapeutics, Inc. Class A stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.

Current score: 2.732 Buy Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $15.25 ( 1.57%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk